Lawrence Leventhal
Rheumatology · Huntingdon Valley, PANPI 1174521165
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $916,194 of the $1,105,412 with a category attached, or 82.9%. 22 manufacturers reported payments, led by Amgen at 30.2% of the total. Reporting peaked in 2019 at $396,916 and has fallen 89.5% since, to $41,808 in 2025. Among rheumatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,492 payments — averaging $740.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$334K
- Lilly USA, LLC$317K
- AbbVie$224K
- Novartis$73K
- Bristol Myers Squibb$62K
- UCB, Inc.$40K
- plus $56K from 16 others
Across 4 payments — averaging $8543.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$34K
What the payments were for
- Consulting fees$42,0554%
- Speaking & faculty fees$916,19483%
- Travel & lodging$124,35911%
- Food & beverage$22,7512%
- Education$530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 435 | $334,025 |
| Lilly USA, LLC | 399 | $317,272 |
| AbbVie | 310 | $224,206 |
| Novartis | 102 | $72,556 |
| Bristol Myers Squibb | 58 | $61,797 |
| UCB, Inc. | 53 | $40,051 |
| Sanofi | 33 | $28,993 |
| E.r. Squibb & Sons, L.L.C. | 29 | $14,474 |
| Pfizer | 19 | $5,965 |
| Regeneron Healthcare Solutions, Inc. | 9 | $3,862 |
| Janssen Research & Development, LLC | 9 | $1,317 |
| Mallinckrodt Hospital Products Inc. | 5 | $247 |
| Mallinckrodt Enterprises LLC | 6 | $158 |
| GSK | 6 | $150 |
| Pacira Therapeutics, Inc. | 5 | $89 |
| Sobi, Inc | 3 | $76 |
| Genentech USA, Inc. | 3 | $56 |
| Radius Health, Inc. | 2 | $41 |
| Hikma Pharmaceuticals USA | 2 | $26 |
| Medexus Pharma, Inc. | 2 | $24 |
| AstraZeneca | 1 | $15 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,105,412 in reported general payments places this provider in the 95th percentile of 351 rheumatology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Allopurinol | 15 | $298 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Huntingdon Valley
- Savita SinghHuntingdon Valley$26K
- Alan EpsteinPhiladelphia$1.2M
- Alan KivitzDuncansville$936K
- Paula HerringNewtown Square$920K
- Rohit AggarwalPittsburgh$810K
- Frederick MurphyDuncansville$494K
- Peter MerkelRadnor$479K
- Martin BergmanRidley Park$458K
- Alexis Ogdie-BeattyPhiladelphia$433K
- Ellen FieldBethlehem$418K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.